On September 22, 2021, the Board of Directors of Blade Air Mobility, Inc. appointed Reginald Love as an independent director of the Company, effective as of September 22, 2021. Mr. Love will be a Class I director, with a term expiring at the Company’s next annual meeting of stockholders. Mr. Love will replace David Zaslav as a Class I director, upon Mr. Zaslav’s resignation from the Board effective September 22, 2021. Mr. Zaslav’s resignation from the Board was not the result of any disagreement with the Company. The Board has appointed Mr. Love to serve on the Nominating and Corporate Governance Committee of the Board (the Committee), effective upon his appointment to the Board. Love is a Senior Advisor at Apollo Global Management and Prior to Apollo, Love served as a Partner at RON Transatlantic EG.
Blade Air Mobility, Inc. provides air transportation and logistics for hospitals across the United States. The Company transports human organs for transplant, and for passengers, with helicopter and fixed wing services primarily in the Northeast United States, Southern Europe and Western Canada. The Company's segments include Passenger and Medical. Its Passenger segment includes Short Distance and Jet and Other. Short Distance business consists primarily of helicopter and amphibious seaplane flights in the United States, Canada and Europe. Jet and Other business consist principally of non-medical jet charter and by-the-seat jet flights between New York and South Florida. Its Medical segment includes MediMobility Organ Transport, which consists primarily of transportation of human organs for transplant and/or the medical teams supporting these services. It also offers additional services including donor logistics coordination and support for evaluating potential donor organs.
BLADE AIR MOBILITY, INC. 
